Large datasets shed light on benign urologic conditions
November 6th 2018In this interview, J. Quentin Clemens, MD, discusses the work being done by the MAPP (Multidisciplinary Approach to Chronic Pelvic Pain) Research Network and LURN (Symptoms of Lower Urinary Tract Dysfunction Research Network) research initiatives.
Female Urology: SUI procedures show decrease following sling warnings
August 14th 2018A comparison of autologous fascial pubovaginal and synthetic midurethral slings and a study examining onabotulinumA (Botox) injections in the elderly population were among other female urology take-homes from AUA 2018.
Sacral neuromodulation, botulinum show equal efficacy
November 14th 2017In patients with refractory urgency urinary incontinence (UUI), sacral neuromodulation (InterStim) and onabotulinumtoxinA (Botox) produce similar reductions in mean daily UUI episodes, according to 24-month follow-up data on patients treated in a randomized trial.
Female Urology: How dynamic MRI compares with physical exam for evaluating POP
July 13th 2017A study that found that age was more strongly associated with selection of colpocleisis than frailty and a comparison of two common wide pore polypropylene Y meshes were among the noteworthy female urology/incontinence research at the AUA annual meeting in Boston.
Urology, gynecology collaboration addresses rising demand
January 1st 2017In this interview, Sarah E. McAchran, MD, discusses the need for urology-gynecology collaboration, the background behind the ABMS recognizing the female pelvic medicine and reconstructive surgery subspecialty, and how barriers to full integration of providers treating pelvic floor disorders can be overcome.
Former Olympian Retton shares her struggle with OAB, launches educational campaign
May 24th 2005For most of her life, former Olympic gymnast Mary Lou Retton suffered from severe urgency and frequency related to overactive bladder. It wasn't until she consulted a urologist just over a year ago that Retton, now 37, received relief from her sometimes debilitating symptoms.Retton has gone public with her personal struggle in a campaign backed by Pfizer. She said she hopes her own experience will help others with the condition seek proper care.